Discover the full management transaction log of National Healthcare CORP, a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, National Healthcare CORP has logged 48 insider filings. Market capitalisation: €2.1bn. The latest transaction was filed on 14 April 2026 — Retenue fiscale. Among the most active insiders: FLATT BEN ANDERSON SR. Every trade is openly available.
25 of 48 declarations
National HealthCare Corporation (NHC) is a United States-based healthcare operator listed on NYSE American under the ticker NHC. Founded in 1971 and headquartered in Murfreesboro, Tennessee, the company has developed an integrated senior care platform focused on post-acute and long-term care. Its core business spans skilled nursing facilities, assisted living communities, independent living facilities, homecare agencies, hospice services, and behavioral health hospitals. NHC also generates revenue from related ancillary activities such as management services, accounting and financial services, insurance services, and property rental income tied to certain healthcare assets. From an industry perspective, NHC sits within the broader U.S. senior housing and post-acute care landscape, where operational execution, clinical quality, reimbursement mix, and labor management are critical. The company’s model is diversified across care settings, but its economic engine remains tied to inpatient senior care and post-acute services. That makes NHC less of a pure real-estate or pure acute-care story and more of a vertically integrated healthcare operator with exposure to recurring needs from an aging population. Geographically, NHC has a meaningful regional footprint across multiple U.S. states, with especially strong exposure in the Southeast, including Tennessee, South Carolina, North Carolina, Florida, and Virginia. This regional concentration can be advantageous because it supports referral relationships, staffing depth, and operational familiarity with state-specific reimbursement and licensing regimes. At the same time, the business is subject to a highly regulated environment, with reimbursement, staffing, and compliance standards that can materially affect margins and growth. In competitive terms, NHC differentiates itself through a mix of service breadth, operating discipline, and facility quality rather than through scale alone. The company has highlighted relatively strong ratings across its skilled nursing portfolio, which matters in a sector where quality metrics influence referral flow, payer confidence, and family decision-making. NHC’s business is also supported by ancillary capabilities such as insurance and management services, which add some diversification to the earnings base. A major recent development was the acquisition of White Oak on August 1, 2024. That transaction added 15 skilled nursing facilities, two assisted living facilities, four independent living facilities, and a long-term care pharmacy in South Carolina and North Carolina. The deal expanded NHC’s operating base and helped drive 2025 results, as the company benefited from a full year of White Oak operations. However, the company also noted higher interest expense linked to acquisition-related debt and unfavorable claims activity in its captive insurance business. For investors, NHC remains a U.S. listed healthcare name on NYSE American with a defensive, demographic-driven thesis, balanced by reimbursement sensitivity and execution risk in a heavily regulated industry.